|
PGM2L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91500000001898E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.21440000000217E-05 |
| Normal-vs-Stage2 |
2.156200E-02 |
| Normal-vs-Stage3 |
6.337800E-02 |
| Normal-vs-Stage4 |
5.520000E-01 |
| Stage1-vs-Stage2 |
8.091800E-01 |
| Stage1-vs-Stage3 |
9.085400E-01 |
| Stage1-vs-Stage4 |
2.867400E-01 |
| Stage2-vs-Stage3 |
9.449400E-01 |
| Stage2-vs-Stage4 |
2.647400E-01 |
| Stage3-vs-Stage4 |
4.271200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61778999999695E-05 |
| Normal-vs-AfricanAmerican |
2.716100E-03 |
| Normal-vs-Asian |
4.113600E-01 |
| Caucasian-vs-AfricanAmerican |
9.629200E-01 |
| Caucasian-vs-Asian |
7.648200E-01 |
| AfricanAmerican-vs-Asian |
7.689200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.244690E-03 |
| Normal-vs-Female |
5.64130000046958E-07 |
| Male-vs-Female |
3.179400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.822500E-02 |
| Normal-vs-Extreme_Weight |
5.298900E-03 |
| Normal-vs-Obese |
9.79899999999922E-05 |
| Normal-vs-Extreme_Obese |
4.765800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.746200E-01 |
| Normal_Weight-vs-Obese |
5.254000E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.373400E-01 |
| Extreme_Weight-vs-Obese |
1.356480E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.545200E-01 |
| Obese-vs-Extreme_Obese |
1.713440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.779800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.43490000004132E-06 |
| Normal-vs-Age(61-80Yrs) |
1.799650E-03 |
| Normal-vs-Age(81-100Yrs) |
9.230000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.994200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.081580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.948300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.208400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.11090000000036E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.090120E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.56593999999233E-05 |
| Normal-VS-Type2 PRCC |
2.453000E-01 |
| Normal-VS-KIRP CIMP |
7.898600E-03 |
| Normal-VS-Unclassified PRCC |
3.180900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.638900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.801500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.218430E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.108220E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.659700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.391600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.342400E-02 |
| Normal-vs-N1 |
3.582500E-02 |
| Normal-vs-N2 |
4.114000E-01 |
| N0-vs-N1 |
2.171800E-01 |
| N0-vs-N2 |
5.658800E-01 |
| N1-vs-N2 |
8.608800E-01 |
|
|
